Plummer HS. Results of administering iodine to patients having exophthalmic goiter. JAMA. 1923;80:1955.
Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:593–646.
Werga-Kjellman P, Zedenius J, Tallstedt L, Traisk F, Lundell G, Wallin G. Surgical treatment of hyperthyroidism: a ten-year experience. Thyroid. 2001;11:187–92.
Barakate MS, Agarwal G, Reeve TS, Barraclough B, Robinson B, Delbridge LW. Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease. ANZ J Surg. 2002;72:321–4.
Chiang FY, Wang LF, Huang YF, Lee KW, Kuo WR. Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve. Surgery. 2005;137:342–7.
Lal G, Ituarte P, Kebebew E, Siperstein A, Duh QY, Clark OH. Should total thyroidectomy become the preferred procedure for surgical management of Graves’ disease? Thyroid. 2005;15:569–74.
Ku CF, Lo CY, Chan WF, Kung AW, Lam KS. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves’ disease. ANZ J Surg. 2005;75:528–31.
Weber KJ, Solorzano CC, Lee JK, Gaffud MJ, Prinz RA. Thyroidectomy remains an effective treatment option for Graves’ disease. Am J Surg. 2006;191:400–5.
Gaujoux S, Leenhardt L, Tresallet C, et al. Extensive thyroidectomy in Graves’ disease. J Am Coll Surg. 2006;202:868–73.
Feliciano DV, Lyons JD. Thyroidectomy is optimal treatment for Graves’ disease. J Am Coll Surg. 2011;212:714–20.
Hallgrimsson P, Nordenstrom E, Almquist M, Bergenfelz AO. Risk factors for medically treated hypocalcemia after surgery for Graves’ disease: a Swedish multicenter study of 1,157 patients. World J Surg. 2012;36:1933–42.
Zambudio AR, Rodriguez J, Riquelme J, Soria T, Canteras M, Parrilla P. Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg. 2004;240:18–25.
Agarwal G, Aggarwal V. Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg. 2008;32:1313–24.
Rienhoff WF. The histological changes brought about in cases of exophthalmic goiter by the administration of iodine. Bull Johns Hopkins Hosp. 1925;37:285–306.
Langley RW, Burch HB. Perioperative management of the thyrotoxic patient. Endocrinol Metab Clin N Am. 2003;32:519–34.
Ansaldo GL, Pretolesi F, Varaldo E, et al. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol’s iodide solution in patients with diffuse toxic goiter. J Am Coll Surg. 2000;191:607–12.
Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN. Lugol’s iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg. 1985;72:45–7.
Chang DC, Wheeler MH, Woodcock JP, et al. The effect of preoperative Lugol’s iodine on thyroid blood flow in patients with Graves’ hyperthyroidism. Surgery. 1987;102:1055–61.
Coyle PJ, Mitchell JE. Thyroidectomy: is Lugol’s iodine necessary? Ann R Coll Surg Engl. 1982;64:334–5.
Marmon L, Au FC. The preoperative use of iodine solution in thyrotoxic patients prepared with propranolol. Is it necessary? Am Surg. 1989;55:629–31.
Yabuta T, Ito Y, Hirokawa M, et al. Preoperative administration of excess iodide increases thyroid volume of patients with Graves’ disease. Endocr J. 2009;56:371–5.
Erbil Y, Ozluk Y, Giris M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves’ disease. J Clin Endocrinol Metab. 2007;92:2182–9.